Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
In addition, there are potentially other less-characterized pathways involving NLRP6, NLRP7, NLRP12, RIG-I, and IFI16
10.1016/j.heliyon.2023.e15613 73 MorganM
Targeting CAFs and ECM remodeling is a promising strategy (Fig
Taken together, these findings suggest that APR-246 could induce tumor cell death through both reactivation of mutant p53 and inhibition of cellular thiol-dependent redox system proteins (GPX4, TXNDR1, GRX1), providing novel combinatorial strategies for AML therapy
N-Acetylcysteine as adjuvant therapy for COVID-19 a perspective on the current state of the evidence
US$ 23.88
US$ 24.35
US$ 24.59
US$ 25.13
US$ 28.57
